SSREY Stock DD Swiss Re Ltd 08/11/2014 11:25:18

New Post Public Reply Private Reply Replies (0) Message Board

Aug 11, 2014 at 12:25 PM

SSREY Swiss Re Ltd $SSREY Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=SSREY&am...mp;yt0=Go!

Last Updated: 08/11/2014 11:25:14

Current Price and Quotes
Last Price 80.9875
Previous Close 80.61 Open 81.23
Daily Range 80.71 - 81.23 52wk Range 75.31 - 95.30
Volume 5,880 Dividend 8.9973
Average Vol (30d) 6,187 Yield 11.1

Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 33,624,000 28,083,000 28,835,000
Cost of Revenue 21,189,000 21,245,000 10,933,000
Gross Profit 12,435,000 6,838,000 17,902,000
Operating Expenses

Research and Development - - -
Sales, General and Admin. - - 10,498,000
Non-Recurring Items - - -
Other 6,176,000 3,112,000 3,371,000
Operating Income 5,523,000 2,875,000 2,675,000
Income From Continuing Operations

Add'l Income/Expense Items - - (264,000)
Earnings Before Interest and Tax 6,259,000 3,726,000 3,769,000
Interest Expense 736,000 851,000 1,094,000
Earnings Before Tax 5,523,000 2,875,000 2,675,000
Income Tax 1,125,000 77,000 541,000
Minority Interest 141,000 172,000 154,000
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations 4,398,000 2,798,000 2,134,000
Non Recurring Events

Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income 4,257,000 2,626,000 1,980,000
Preferred Stock and Other Adjustments (56,000) - (1,117,000)
Net Income Applicable to Common Shareholders 4,201,000 2,626,000 863,000

Recent News

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Beef 'O' Brady's Expands Into Tuscaloosa Market

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

CVS Study: GLP-1 Drugs Effective But Costly

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...